Biomimetic Studies on Anti-Thyroid Drugs and Thyroid Hormone Synthesis

Roy, Gouriprasanna and Nethaji, Munirathinam and Mugesh, G (2004) Biomimetic Studies on Anti-Thyroid Drugs and Thyroid Hormone Synthesis. In: Journal of the American Chemical Society, 126 (9). pp. 2712-2713.

PDF Biomimetic-567.pdf Restricted to Registered users only Download (51kB) | Request a copy

Abstract

Thyroxine (T4) is the main secretory product of the thyroid gland, and the deiodination of this prohormone to the biologically active hormone, 3,5,3'-triiodothyronine (T3), is the first step in thyroid hormone action. It is well known that type I iodothyronine deiodinase (ID-1), a selenocysteine-containing enzyme, is responsible for most of this conversion.1 The activation of thyroid stimulating hormone (TSH) receptor by autoantibodies leads to an overproduction of thyroid hormones, which can be controlled by specific inhibitors such as 6-n-propyl-2-thiouracil (1, PTU) and methimazole (3, MMI) that either block the thyroid hormone biosynthesis or reduce the conversion of T4 to $T3.^1$

Item Type:	Journal Article
Publication:	Journal of the American Chemical Society
Publisher:	American Chemical Society
Additional Information:	The copyright of this article belongs to American Chemical Society.
Department/Centre:	Division of Chemical Sciences > Inorganic & Physical Chemistry
Date Deposited:	20 Nov 2007
Last Modified:	19 Sep 2010 04:27
URI:	http://eprints.iisc.ac.in/id/eprint/7075

Actions (login required)

View Item